VEGFA and neoplasm: Bevacizumab is an anti-neoplastic medication that works primarily by inhibiting the receptors of vascular endothelial growth factor (VEGF), which limits the formation of new blood vessels and effectively disrupts a tumor's supply of oxygen and nutrients [18].